ROG - Roche Holding AG
SIX
->
Healthcare
->
Drug Manufacturers—General
Basel,
Switzerland
Type: Equity
ROG price evolution
ROG
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $119.9 | $116.9 | $131.7 | |
| Short term investments | ||||
| Net receivables | $188.7 | $160 | $159.2 | $161.9 |
| Inventory | $154.4 | $150.8 | $150.9 | $153.5 |
| Total current assets | $521.2 | $502.1 | $501.4 | $526.9 |
| Long term investments | $9.7 | $10.9 | $11.1 | |
| Property, plant & equipment | $406.8 | $383.3 | $382 | $385.2 |
| Goodwill & intangible assets | $473.5 | $477.5 | $483.7 | |
| Total noncurrent assets | $985 | $986.6 | $990.3 | |
| Total investments | $9.7 | $10.9 | $11.1 | |
| Total assets | $1540 | $1487.1 | $1488 | $1517.2 |
| Current liabilities | ||||
| Accounts payable | $47.2 | $49.9 | $51.7 | $50.3 |
| Deferred revenue | ||||
| Short long term debt | $3.7 | $3.8 | $3.5 | |
| Total current liabilities | $122.5 | $116.5 | $117 | $116.4 |
| Long term debt | $14.1 | $15.1 | $45.4 | |
| Total noncurrent liabilities | $109.8 | $111.2 | $141.8 | |
| Total debt | $17.8 | $18.9 | $48.9 | |
| Total liabilities | $239.3 | $226.3 | $228.2 | $258.2 |
| Shareholders' equity | ||||
| Retained earnings | $1181.6 | $1170.9 | $1162.8 | $1155 |
| Other shareholder equity | -$55.2 | -$81.1 | -$75.5 | -$66.4 |
| Total shareholder equity | $1260.8 | $1259.8 | $1259 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $131.7 | $235.85 | $232.3 | $191.78 |
| Short term investments | ||||
| Net receivables | $161.9 | $220.15 | $163.09 | $134.42 |
| Inventory | $153.5 | $182.4 | $133.38 | $102.36 |
| Total current assets | $526.9 | $659.87 | $584.07 | $474.18 |
| Long term investments | $11.1 | $14.08 | $16.33 | $15.25 |
| Property, plant & equipment | $385.2 | $371.43 | $326.97 | $272.38 |
| Goodwill & intangible assets | $483.7 | $486.09 | $546.54 | $388.2 |
| Total noncurrent assets | $990.3 | $986.35 | $1014.5 | $789.83 |
| Total investments | $11.1 | $14.08 | $16.33 | $15.25 |
| Total assets | $1517.2 | $1646.21 | $1598.57 | $1264.01 |
| Current liabilities | ||||
| Accounts payable | $50.3 | $57.34 | $64.66 | $35.99 |
| Deferred revenue | ||||
| Short long term debt | $3.5 | $0.5 | ||
| Total current liabilities | $116.4 | $142.54 | $163.95 | $111.51 |
| Long term debt | $45.4 | $216.29 | $190 | $25 |
| Total noncurrent liabilities | $141.8 | $331.21 | $315.72 | $131.74 |
| Total debt | $48.9 | $216.79 | $190 | $25 |
| Total liabilities | $258.2 | $473.75 | $479.67 | $243.25 |
| Shareholders' equity | ||||
| Retained earnings | $1155 | $1098.45 | $981.83 | $873.69 |
| Other shareholder equity | -$66.4 | -$85.26 | -$45.24 | -$19.57 |
| Total shareholder equity | $1259 | $1172.47 | $1118.89 | $1020.75 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $210.3 | $213.4 | $204.58 | |
| Cost of revenue | $145.2 | $137.16 | ||
| Gross Profit | $74.1 | $68.2 | $67.42 | |
| Operating activities | ||||
| Research & development | $8.9 | $10.19 | ||
| Selling, general & administrative | $47.5 | $51.75 | ||
| Total operating expenses | $53.2 | $56.5 | $36.89 | |
| Operating income | $11.7 | $30.54 | ||
| Income from continuing operations | ||||
| EBIT | $12.4 | $30.07 | ||
| Income tax expense | $2.8 | $3.8 | $5.39 | |
| Interest expense | $0.4 | $0.8 | $1.47 | |
| Net income | ||||
| Net income | $10.7 | $7.8 | $23.21 | |
| Income (for common shares) | $7.8 | $23.21 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $908.4 | $971.17 | $932.89 | $802.58 |
| Cost of revenue | $601.3 | $650.16 | $583.75 | $510.76 |
| Gross Profit | $307.1 | $321.01 | $349.14 | $291.82 |
| Operating activities | ||||
| Research & development | $35.7 | $35.21 | $29.9 | $29.32 |
| Selling, general & administrative | $202.3 | $218.83 | $193.15 | $182.28 |
| Total operating expenses | $221.8 | $176.58 | $232.49 | $224.54 |
| Operating income | $85.3 | $144.43 | $116.65 | $67.28 |
| Income from continuing operations | ||||
| EBIT | $86.4 | $149.93 | $128.82 | $75.67 |
| Income tax expense | $19.7 | $23.75 | $18.15 | $18.54 |
| Interest expense | $10.1 | $9.55 | $2.54 | $7.13 |
| Net income | ||||
| Net income | $56.6 | $116.63 | $108.13 | $49.99 |
| Income (for common shares) | $56.6 | $116.63 | $108.13 | $49.99 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $8.1 | $7.8 | $23.21 | |
| Operating activities | ||||
| Depreciation | $12.3 | $11.3 | $11.28 | |
| Business acquisitions & disposals | $0.01 | |||
| Stock-based compensation | $5.3 | $3.5 | $3.43 | |
| Total cash flows from operations | $22.9 | $28.1 | $71.88 | |
| Investing activities | ||||
| Capital expenditures | -$14.1 | -$9.4 | -$17.61 | |
| Investments | ||||
| Total cash flows from investing | -$40.7 | -$14.1 | -$9.4 | -$17.55 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$6.7 | -$0.3 | ||
| Net borrowings | -$0.1 | -$30.1 | -$50.07 | |
| Total cash flows from financing | -$38.6 | -$6.9 | -$31.5 | -$50.69 |
| Effect of exchange rate | $0.6 | $1.1 | -$2 | $1.56 |
| Change in cash and equivalents | $14.7 | $3 | -$14.8 | $5.2 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $56.6 | $116.63 | $108.13 | $49.99 |
| Operating activities | ||||
| Depreciation | $51.1 | $45.88 | $43.28 | $71.42 |
| Business acquisitions & disposals | $1.7 | -$3.58 | -$168.2 | |
| Stock-based compensation | $14.3 | $11.8 | $16.99 | $13.53 |
| Total cash flows from operations | $131.4 | $129.46 | $124.36 | $165.06 |
| Investing activities | ||||
| Capital expenditures | -$51.4 | -$116.79 | -$70.41 | -$40.38 |
| Investments | ||||
| Total cash flows from investing | -$47.9 | -$113.12 | -$238.62 | -$40.38 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$24.05 | $1.56 | $1.36 | |
| Net borrowings | -$185.4 | $24.73 | $160.38 | -$98.33 |
| Total cash flows from financing | -$190.3 | -$10.1 | $159.06 | -$104.19 |
| Effect of exchange rate | $2.6 | -$2.69 | -$4.29 | $4.45 |
| Change in cash and equivalents | -$104.2 | $3.55 | $40.51 | $24.94 |
News
Fundamentals
| Market cap | $5.48B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 18.60M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -8.23% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.21 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 4.25 |
| Quick ratio | 2.99 |